Contingent Consideration - Schedule of Reconciliation of Contingent Consideration Liability Related to Acquisition (Details) - USD ($) $ in Thousands	8 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2021
Business Acquisition, Contingent Consideration [Line Items]
Change in fair value of contingent consideration		$ 4,237
Kuur Therapeutics, Inc.
Business Acquisition, Contingent Consideration [Line Items]
Balance as of December 31, 2021	$ 24,076	24,076
Kuur Therapeutics, Inc. | Significant Unobservable Inputs (Level 3)
Business Acquisition, Contingent Consideration [Line Items]
Balance as of December 31, 2021	24,076	24,076
Kuur Therapeutics, Inc. | Significant Unobservable Inputs (Level 3) | Fair Value, Recurring
Business Acquisition, Contingent Consideration [Line Items]
Balance as of May 4, 2021	19,839
Change in fair value of contingent consideration	4,237
Balance as of December 31, 2021	$ 24,076	$ 24,076